EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells

Mobin Emran Doost, Jennifer Hong, Jennifer E Broatch, Michael T Applegate, Carl E Wagner, Pamela A Marshall iD, Peter W Jurutka iD

Cells · 14.11.2024 · 13 (22) · 1878

DOI: 10.3390/cells13221878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 14.11.2024. Verfasst von Mobin Emran Doost und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematical and Natural Sciences, Arizona State University, Glendale, AZ 85306, USA. Hauptthemen laut MEDLINE: Receptors, Calcitriol, Retinoid X Receptors, Vitamin D, Brain. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIH 1R15CA249617.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25D), binds to the vitamin D receptor (VDR) with high affinity. The VDR then heterodimerizes with the retinoid X receptor (RXR) and associates with vitamin D response elements (VDREs) to regulate the transcription of target genes. Bexarotene (Bex) is an RXR ligand (rexinoid) developed to treat cutaneous T-cell lymphoma and is a putative therapeutic for other diseases. We postulate that VDR ligands (1,25D) and RXR ligands (Bex/analogs) can “synergize” to “super-activate” the VDR-RXR heterodimer. This “cross-talk” could allow disorders treated with high-dose Bex therapy (leading to significant adverse side effects) to instead be treated using both low-dose Bex and vitamin D. Thus, we designed experiments to examine the effect of both VDR and RXR ligands, alone and in combination, to activate VDR-RXR-mediated transcription. The goal was to determine if selected RXR-specific ligands can synergize with vitamin D to amplify RXR-VDR activity. The results demonstrate a synergistic effect with both Bex and 1,25D which could be further modulated by (1) the protein levels (or polymorphic version) of VDR present in the cell, (2) the concentration of the ligands, (3) the cellular “background” (e.g., brain cells versus kidney cells), (4) the nature of the VDRE platform, or (5) the type of rexinoid (Bex analogs). Our findings suggest that diseases that respond to treatment with either vitamin D, or with rexinoids, may be amenable to enhanced therapeutic potential by employing multi-ligand dosing via combinatorial therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CalcitriolRetinoid X ReceptorsVitamin DBrainBexaroteneHumansKidneyLigandsDrug SynergismProtein Multimerization

Stichwörter der Autor:innen

RXRpolymorphismsrexinoidssynergismvitamin Dvitamin D receptor

Substanzen

Receptors, CalcitriolRetinoid X ReceptorsVitamin DBexaroteneLigandsVDR protein, human

Autor:innen und Institutionen

  • School of Mathematical and Natural Sciences, Arizona State University, Glendale, AZ 85306, USA.

ORCID-Profile: Pamela A Marshall, Peter W Jurutka

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NIH 1R15CA249617
  • Arizona State University, Barrett, the Honors College
  • New College Undergraduate Inquiry and Research Experiences (NCUIRE)
  • School of Life Sciences Undergraduate Research Program (SOLUR)

Zitieren

APA

Doost, M. E., Hong, J., Broatch, J. E., Applegate, M. T., Wagner, C. E., Marshall, P. A., & Jurutka, P. W. (2024). Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells. Cells, 13(22), 1878. https://doi.org/10.3390/cells13221878

Vancouver

Doost ME, Hong J, Broatch JE, Applegate MT, Wagner CE, Marshall PA, et al. Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells. Cells. 2024;13(22):1878. doi:10.3390/cells13221878

BibTeX
@article{Doost2024,
  author = {Doost, Mobin Emran and Hong, Jennifer and Broatch, Jennifer E and Applegate, Michael T and Wagner, Carl E and Marshall, Pamela A and Jurutka, Peter W},
  title = {Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {22},
  pages = {1878},
  doi = {10.3390/cells13221878}
}
Kostenlos starten →